Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

0.8100 +0.0400 (+5.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
34 35 Next >
Why Ocugen Stock Popped by 7% on Tuesday
A third-quarter report, complete with clinical updates, is more than enough to satisfy the biotech's bulls. 
Via The Motley Fool
Ocugen, Inc. (OCGN) Q3 2022 Earnings Call Transcript
OCGN earnings call for the period ending September 30, 2022. 
Via The Motley Fool
SolarEdge Technologies, LivePerson, TaskUs And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Ocugen Provides Business Update & Third Quarter 2022 Financial Results
From Ocugen
Via GlobeNewswire
Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
Gainers 
Via Benzinga
Why Is Ocugen (OCGN) Stock Up Today?
OCGN stock is getting a boost today on news that Ocugen is partnering with Washington University on its Covid-19 vaccine. 
Via InvestorPlace
3 High-Octane Growth Stocks With 357% to 571% Upside, According to Wall Street
Select analysts and pundits foresee game-changing upside from this fast-paced trio. 
Via The Motley Fool
Warning! Don’t Even Consider Buying These 7 Dead-Money Stocks
These dead-money stocks exhibit incredible volatility and present themselves as remarkably risky bets in this current economic environment. 
Via InvestorPlace
Ocugen to Host Conference Call on Tuesday, November 8 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2022 Financial Results
From Ocugen
Via GlobeNewswire
Ocugen to Host R&D Day in New York City on Tuesday, November 1, 2022
From Ocugen
Via GlobeNewswire
Ocugen Inks US Development Pact For Its Intranasal COVID-19 Vaccine
Via Benzinga
What Happened With Ocugen Shares During Wednesday's After-Hours Session
Ocugen Inc (NASDAQ: OCGN) shares traded marginally higher by 1.22% at $1.66 during Wednesday's after-hours session. 
Via Benzinga
Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2
From Ocugen
Via GlobeNewswire
What Is Going on With AMTD Digital (HKD) Stock Today?
HKD stock is soaring for a second day. Since no major news about the company was reported, it appears that the stock has become a meme play. 
Via InvestorPlace
Why Missfresh Shares Are Trading Lower; Here Are 30 Stocks Moving Premarket
Gainers M-tron Industries, Inc. (NASDAQ: MPTI) rose 57.9% to $24.00 in pre-market trading after surging 10% on Friday. M-tron Industries completed its earlier announced separation from The LGL Group,... 
Via Benzinga
Wall Street Thinks This Top 100 Robinhood Stock Could Skyrocket by 217%
Can this vaccine maker turn things around? 
Via The Motley Fool
Ocugen, Inc. to Present at Upcoming Vaccines, Cell & Gene Therapy Conferences
From Ocugen
Via GlobeNewswire
Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference
From Ocugen
Via GlobeNewswire
LYFT Stock Alert: What to Know as Lyft Pumps the Brakes on Hiring
Lyft (LYFT) stock is getting a boost on Wednesday after the ride-sharing company revealed a stop to hiring for the rest of the year. 
Via InvestorPlace
Apple (AAPL) Stock Sinks After Slowing iPhone Production
Apple (AAPL) stock is slipping on Wednesday after the tech company revealed plans to slow production for its iPhone line. 
Via InvestorPlace
So What's Happening With Ocugen Stock Today?
Ocugen Inc (NASDAQ: OCGN) shares are trading higher by 3.35% to $1.88 Wednesday morning after the company announced it entered into an exclusive license agreement with Washington University in St. 
Via Benzinga
Ocugen Announces Agreement With Washington University in St. Louis for Commercialization of Intranasal COVID-19 Vaccine in U.S., Europe, and Japan
From Ocugen
Via GlobeNewswire
Ford, Evotec And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning after recording gains in the previous session. Here are some big stocks moving lower in today’s pre-market trading session. 
Via Benzinga
Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket
Gainers 
Via Benzinga
Why Ocugen Shares Are Diving
Ocugen Inc (NASDAQ: OCGN) shares are trading lower by 4.15% to $2.08 Monday morning. Shares of several vaccine companies at large are trading lower possibly after President Biden in a '60 Minutes'... 
Via Benzinga
MarketBeat: Week in Review 8/22 - 8/26
The markets are selling on news that interest rate hikes will continue past September. But here are some of the other stories for investors to follow this week 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Are Ocugen or Amarin Good Penny Stocks to Buy?
This article discusses the current state of Ocugen and Amarin, two penny stocks that highlight the risk and (potential) reward of penny stock investing. 
Via MarketBeat
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results. 
Via Benzinga
Indonesia Energy (INDO) Stock Soars as Natural Gas Prices Spike
Indonesia Energy (INDO) stock is rising higher on Tuesday alongside the increasing price of natural gas as Europe seeks new fuel sources. 
Via InvestorPlace
Why Is Ocugen (OCGN) Stock Climbing Higher Today?
Ocugen (OCGN) stock is gaining on Tuesday after Mizuho Securities analysts initiated coverage of the medical company's shares. 
Via InvestorPlace
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.